Pharmacokinetics of gemcitabine when delivered by selective pulmonary artery perfusion for the treatment of lung cancer

Drug Metabolism and Disposition

Volumn 36, Issue 4, 2008, Pages 676-681

  Van Putte, Bart P ^a   Grootenboers, Marco ^a   Van Boven, Wim Jan ^a   Hendriks, Jeroen M H ^c   Van Schil, Paul E Y ^c   Guetens, Gunther ^d   De Boeck, Gert ^d   Pasterkamp, Gerard ^e   Schramel, Franz ^a   Folkerts, Gert ^b  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTERY PERFUSION; ARTICLE; BALLOON CATHETER; CATHETERIZATION; CONTROLLED STUDY; CYTOSTASIS; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG LIVER LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFUSION PUMP; LUNG ARTERY; LUNG BLOOD FLOW; LUNG CANCER; LYMPH NODE METASTASIS; NONHUMAN; PRIORITY JOURNAL; SELECTIVE PULMONARY ARTERY PERFUSION; STATISTICAL SIGNIFICANCE; SWINE; THORACOTOMY;

ANIMALS; DEOXYCYTIDINE; DRUG DELIVERY SYSTEMS; FEMALE; INFUSIONS, INTRA-ARTERIAL; LUNG; LUNG NEOPLASMS; PULMONARY ARTERY; SWINE;

SUIDAE;

EID: 41549122414     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.106.014639     Document Type: Article

References (22)

1. Bergman AM, Ruiz Van Raperen VW, Veerman G, Kuiper CM, and Peters GJ (1996) Synergistic interaction between cisplatin and gemcitabine in vitro. Clin Cancer Res 2:521-530.
2. Betticher DC (2005) Adjuvant and neoadjuvant chemotherapy in NSCLC: a paradigm shift. Lung Cancer 50 (Suppl 2):S9-S16.
3. Brown DB, Cai S-R, and Fundakowski CE (2006) Pharmacokinetics after endovascular lung perfusion with cisplatin. J Vasc Interv Radiol 17:883-888.
4. Burt ME, Liu D, and Abolhoda A (2000) Isolated lung perfusion for patients with unresectable metastases from sarcoma: a phase I trial. Ann Thorac Surg 69:1542-1549.
5. De Boeck G, Van Cauwenberghe K, and Eggermont AM (1997) Determination of melphalan and hydrolysis products in body fluids by GC-MS. High Res Chromatog 12:697-700.
6. Furrer M, Lardinois D, and Thormann W (1998) Cytostatic lung perfusion by use of an endovascular blood flow occlusion technique. Ann Thorac Surg 65:1523-1528.
7. Hendriks JMH, Grootenboers M, and Schramel F (2004) Isolated lung perfusion with melphalan for patients with resectable pulmonary metastases: a phase I trial. Ann Thorac Surg 78:1919-1927.
8. Hendriks JMH, Van Schil PEY, and De Boeck G (1998) Isolated lung perfusion with melphalan and tumour necrosis factor for metastatic pulmonary adenocarcinoma. Ann Thorac Surg 66:1719-1725.
9. Jemal A, Siegel R, and Ward E (2006) Cancer statistics 2006. CA Cancer J Clin 56:106-130.
10. Karakousis CP, Park HC, and Sharma SD (1981) Regional chemotherapy via the pulmonary artery for pulmonary metastases. J Surg Oncol 18:249-255.
11. Miller BJ and Rosenbaum AS (1967) The vascular supply to metastatic tumours of the lung. Surg Gynecol Obstet 125:1009-1012.
12. Mochizuki A, Kurihara Y, and Yokote K (2000) Discrimination of solitary pulmonary nodules based on vascular supply patterns with first-pass dynamic CT. Lung Cancer 29 (Suppl 1):242.
13. Pass HI, Mew DJY, and Kranda KC (1996) Isolated lung perfusion with tumor necrosis factor for pulmonary metastases. Ann Thorac Surg 61:1609-1617.
14. Peters GJ, Van Moorsel CJ, and Lakerveld B (2006) Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or resistant human ovarian cancer cell lines. Int J Oncol 28:237-244.
15. Ratto GB, Toma S, and Civalleri D (1996) Isolated lung perfusion with platinum in the treatment of pulmonary metastases from soft tissue sarcomas. J Thorac Cardiovasc Surg 112:614-622.
16. Rivera MP, Detterbeck FC, and Loomis DP (2001) Diagnosis and treatment of lung cancer: an evidence-based guide for the practicing clinician, in Pulmonary Assessment and Treatment (Detterbeck FC, Rivera MP, Socinski MS, and Rosenman JG eds) pp 191-197, WB Saunders, Philadelphia.
17. Spiro SG and Silvestri GA (2005) One hundred years of lung cancer. Am J Resp Crit Care Med 172:523-529.
18. van Putte BP, Hendriks JMH, and Guetens G (2006) Modified approach of administering cytostatics to the lung: more efficient isolated lung perfusion. Ann Thorac Surg 82:1033-1037.
19. van Putte BP, Hendriks JMH, and Romijn S (2005) Combination chemotherapy with gemcitabine using isolated lung perfusion for the treatment of pulmonary metastases. J Thorac Cardiovasc Surg 130:125-130.
20. van Putte BP, Hendriks JMH, and Romijn S (2003a) Isolated lung perfusion with gemcitabine in a rat: pharmacokinetics and survival. J Surg Res 109:118-122.
21. van Putte BP, Hendriks JMH, and Romijn S (2002) Single-pass isolated lung perfusion versus recirculating isolated lung perfusion with melphalan in a rat model. Ann Thorac Surg 74:893-898.
22. van Putte BP, Romijn S, and Hendriks JMH (2003b) Pharmacokinetics after pulmonary artery perfusion with gemcitabine. Ann Thorac Surg 76:1036-1040.